TDOC - NYSE
Teladoc Health, Inc.
$7.31
-3.1%Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
At a Glance
Live Snapshottdoc
Research Development Expenses
Last Annual Value
277.92M
3-Year CAGR
-6%
5-Year CAGR
11%
10-Year CAGR
35%
Teladoc Health, Inc. Competitors Analysis of research-development-expenses
| Company | research-development-expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Teladoc Health, Inc. NYSE:TDOC | 277.92M | -7.3% | -2.3% | 29.0% | |
 Progyny, Inc. NASDAQ:PGNY | 0.00 | N/A | N/A | N/A | |
 Omada Health NASDAQ:OMDA | 40.59M | 6.4% | N/A | N/A | |
 Azenta, Inc. NASDAQ:AZTA | 30.39M | -3.6% | 6.3% | -5.1% | |
 Omnicell, Inc. NASDAQ:OMCL | 87.73M | -2.0% | 3.0% | 4.3% | |
 Schrödinger, Inc. NASDAQ:SDGR | 173.14M | -1.6% | 13.8% | N/A | |
 Immunome, Inc. NASDAQ:IMNM | 174.33M | 96.2% | 65.3% | N/A | |
 NovoCure Limited NASDAQ:NVCR | 224.54M | 0.2% | 2.2% | 18.4% | |
 Phreesia, Inc. NYSE:PHR | 121.48M | 10.0% | 40.0% | N/A |
Teladoc Health, Inc. Fair Value Envelope
Related Guides
Continue your TDOC research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.